Fig. 1From: Elevated serum fibroblast growth factor 23 levels as an indicator of lower extremity atherosclerotic disease in Chinese patients with type 2 diabetes mellitusComparison of serum FGF23 levels between diabetes patients with and without LEAD. Data are shown as median with 25th and 75th percentiles. *P < 0.05 versus without LEADBack to article page